Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2010 Apr 13;10715:6900-5. doi: 10.1073/pnas.0906764107.
Show Gene links
Show Anatomy links
Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family.
Zhang B
,
Abreu JG
,
Zhou K
,
Chen Y
,
Hu Y
,
Zhou T
,
He X
,
Ma JX
.
???displayArticle.abstract???
The Wnt pathway regulates multiple biological and pathological processes including angiogenesis and inflammation. Here we identified a unique inhibitor of the Wnt pathway, SERPINA3K, a serine proteinase inhibitor with anti-inflammatory and angiogenic activities. SERPINA3K blocked the Wnt pathway activation induced by a Wnt ligand and by diabetes. Coprecipitation and ligand binding assay showed that SERPINA3K binds to low-density lipoprotein receptor-like protein 6 (LRP6) with a K(d) of 10 nM, in the range of its physiological concentration in the retina. Under the same conditions, SERPINA3K did not bind to the frizzled (Fz) receptor or low-density lipoprotein receptor. Further, SERPINA3K bound to LRP6 at the extracellular domain and blocked its dimerization with the Fz receptor induced by a Wnt ligand. The antagonizing activity of SERPINA3K to LRP6 was further confirmed by Xenopus axis duplication assay. These results suggest that SERPINA3K is a high-affinity, endogenous antagonist of LRP6. The blockade of Wnt signaling may represent a unifying mechanism for the anti-inflammatory and anti-angiogenic effects of SERPINA3K.
Chao,
Identification of a new tissue-kallikrein-binding protein.
1986, Pubmed
Chao,
Identification of a new tissue-kallikrein-binding protein.
1986,
Pubmed
Chao,
Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats.
1990,
Pubmed
Chen,
Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
2007,
Pubmed
Chen,
Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.
2009,
Pubmed
Clevers,
Wnt/beta-catenin signaling in development and disease.
2006,
Pubmed
Dale,
Signal transduction by the Wnt family of ligands.
1998,
Pubmed
Dawson,
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.
1999,
Pubmed
Easwaran,
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
2003,
Pubmed
Ferrara,
Angiogenesis as a therapeutic target.
2005,
Pubmed
Gao,
Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.
2003,
Pubmed
George,
Wnt pathway: a new role in regulation of inflammation.
2008,
Pubmed
Gettins,
Serpin structure, mechanism, and function.
2002,
Pubmed
Hanai,
Endostatin is a potential inhibitor of Wnt signaling.
2002,
Pubmed
,
Xenbase
Harland,
Formation and function of Spemann's organizer.
1997,
Pubmed
Hatcher,
Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.
1997,
Pubmed
Hatcher,
Kallikrein-binding protein is induced by growth hormone in the dwarf rat.
1999,
Pubmed
He,
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.
2004,
Pubmed
Hosoya,
Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat.
2001,
Pubmed
Howe,
Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells.
1999,
Pubmed
Huang,
High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs.
2008,
Pubmed
Huang,
Alpha1-antitrypsin inhibits angiogenesis and tumor growth.
2004,
Pubmed
Lamalice,
Endothelial cell migration during angiogenesis.
2007,
Pubmed
Liu,
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
2002,
Pubmed
,
Xenbase
Ma,
Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy.
1996,
Pubmed
Mao,
LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.
2001,
Pubmed
,
Xenbase
Masckauchán,
Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight.
2006,
Pubmed
Miao,
Kallistatin is a new inhibitor of angiogenesis and tumor growth.
2002,
Pubmed
Mor,
Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization.
2004,
Pubmed
Nusse,
Wnt signaling in disease and in development.
2005,
Pubmed
Ojesina,
The role of beta-catenin in regulating angiogenesis in Wilms tumor.
2004,
Pubmed
Orsulic,
Cell-cell signalling: Wingless lands at last.
1996,
Pubmed
Polakis,
Casein kinase 1: a Wnt'er of disconnect.
2002,
Pubmed
Pollina,
Regulating the angiogenic balance in tissues.
2008,
Pubmed
Samarzija,
Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways.
2009,
Pubmed
Semënov,
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor.
2005,
Pubmed
,
Xenbase
Semënov,
Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6.
2001,
Pubmed
,
Xenbase
Shellenberger,
Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.
2005,
Pubmed
Tachikawa,
Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins.
2004,
Pubmed
Tamai,
LDL-receptor-related proteins in Wnt signal transduction.
2000,
Pubmed
,
Xenbase
Tamai,
A mechanism for Wnt coreceptor activation.
2004,
Pubmed
,
Xenbase
Yamagishi,
Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
2006,
Pubmed
Yamaji-Kegan,
Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.
2006,
Pubmed
Ye,
Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization.
2009,
Pubmed
You,
Wnt pathway-related gene expression in inflammatory bowel disease.
2008,
Pubmed
Zeng,
Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions.
2008,
Pubmed
,
Xenbase
Zhang,
Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
2006,
Pubmed
Zhang,
SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload.
2008,
Pubmed
Zhang,
Maspin is an angiogenesis inhibitor.
2000,
Pubmed
Zhang,
Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
2001,
Pubmed
Zhang,
Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.
2009,
Pubmed
Zhang,
Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy.
2005,
Pubmed
Zhu,
IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis.
2008,
Pubmed
,
Xenbase
